IRCT20090117001556N142尚未招募2 期
Investigating the effect of Celecoxib on depression induced by COVID-19: A randomized double blind and placebo controlled clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Age between 18 to 60 years
- •At least 20 days after the onset of symptoms and 7 days after the last day the patient was symptomatic, the patient should show a score of 14-17 on HDRS (moderate depression)
排除标准
- •History of depression before infected with COVID-19
- •Any other mental disorder in another axis
- •Taking other psychiatric drugs which can alter cognitive functions
- •History of ECT in recent two months
- •Thyroid dysfunctions
- •Kidney disease
- •Liver disease
- •History of cognitive dysfunction or dementia
- •Pregnant or lactating women
- •Serious suicidal thoughts (<2 in suicidal HDRS section)
研究者
相似试验
已完成
不适用
celecoxib in the treatment of depressed patients with brucellosisMajor depressive disorder.Major Depressive episodeIRCT201405271556N59Tehran University of Medical Sciences50
尚未招募
4 期
A randomized controlled trial to evaluate the effectiveness of Celecoxib vs placebo as an additional treatment for depression in outpatients of Colombo North Teaching hospital Ragama.DepressionSLCTR/2018/027Faculty of Medicine, University of Kelaniya
尚未招募
4 期
Stony Brook Medicine Anti-Inflammatory TrialMajor Depressive DisorderNCT06699966Stony Brook University42
已完成
4 期
The Effect of Celecoxib on Neuroinflammation in MDDNeuroinflammationMajor Depressive DisorderNCT04814355Stony Brook University41
暂停
不适用
A clinical study on the efficacy of celecoxib in patients with postoperative pain (A multicenter, randomized, open-label,parallel-group controlled study of celecoxib vs. loxoprofen)The subjects will be patients who are anticipated to develop postoperative pain that is determined manageable with oral NSAIDsJPRN-UMIN000011302ippon Medical School Department of Orthopaedic Surgery230